AI-generated treatment recommendations versus real-world treatment decisions in newly diagnosed lung cancer: a blinded comparative pilot study (Preprint)
Le résumé fourni par la source
BACKGROUND AI use in clinical decision making is increasingly frequent. How treatment recommendations generated by large language models (LLMs) compare with real-world treatment decisions remains poorly characterized. OBJECTIVE To assess whether AI-generated treatment recommendations are rated as appropriate as real-world MDT decisions in newly diagnosed lung cancer and to test the feasibility of a blinded comparative method. METHODS We designed a pilot study consisting of a blinded comparison of treatment recommendations made by four LLMs (ChatGPT, Claude, Gemini and Grok, accessed via consumer chat interfaces in June 2026) against real-world treatment decisions in a series of 27 consecutive, newly diagnosed lung cancer cases that received treatment in a single institution, from June 2024 to May 2026. A standardized prompt was used to ask AI to generate treatment recommendations. These were extracted in a standardized form, along with the actual treatment received in each case, totaling 135 treatment recommendations; a single blinded reviewer, presented with the recommendations in randomized order per case, graded all of them from 1 (inappropriate) to 5 (fully appropriate) and checked three flags (guideline-concordant, potentially unsafe, local/supportive treatment omitted). Scores were compared across sources using the Friedman rank-sum test. RESULTS The average score was highest for the real-world MDT decision at 4.52, followed by ChatGPT 4.48, Claude 4.44, Grok 4.41 and Gemini 4.37. No statistically significant difference was found (Friedman χ²(4)=1.99, p=0.74). No recommendation received a score lower than 3. Flags were similar across groups. CONCLUSIONS This pilot study did not detect a significant difference in rated appropriateness of treatment recommendations made by AI compared with the treatment actually received by patients. The methodology proved feasible but these findings are hypothesis-generating and require confirmation in larger studies, with more cases and multiple reviewers.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- AI-generated treatment recommendations versus real-world treatment decisions in newly diagnosed lung cancer: a blinded comparative pilot study (Preprint)
- Date Crossref
- 01/08/2026
- Éditeur
- JMIR Publications Inc.
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.